Dam mutants provide improved sensitivity and spatial resolution for profiling transcription factor binding.
Tomasz SzczesnikJoshua W K HoRichard I SherwoodPublished in: Epigenetics & chromatin (2019)
DamID, in which a protein of interest is fused to Dam methylase, enables mapping of protein-DNA binding through readout of adenine methylation in genomic DNA. DamID offers a compelling alternative to chromatin immunoprecipitation sequencing (ChIP-Seq), particularly in cases where cell number or antibody availability is limiting. This comes at a cost, however, of high non-specific signal and a lowered spatial resolution of several kb, limiting its application to transcription factor-DNA binding. Here we show that mutations in Dam, when fused to the transcription factor Tcf7l2, greatly reduce non-specific methylation. Combined with a simplified DamID sequencing protocol, we find that these Dam mutants allow for accurate detection of transcription factor binding at a sensitivity and spatial resolution closely matching that seen in ChIP-seq.
Keyphrases
- dna binding
- transcription factor
- single cell
- genome wide
- rna seq
- high throughput
- single molecule
- dna methylation
- high resolution
- genome wide identification
- circulating tumor cells
- randomized controlled trial
- gene expression
- protein protein
- amino acid
- cell free
- stem cells
- cell therapy
- small molecule
- oxidative stress
- dna damage
- bone marrow
- nucleic acid
- wild type